pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    BEAM-302
    Alpha-1 Antitrypsin Deficiency (A1AD)$BEAM Beam Therapeutics Inc.
  • Phase 2
    BGB-16673
    Refractory Chronic Lymphocytic Leukemia (CLL)$ONC BeOne Medicines Ltd.
  • Phase 2
    BGC-101
    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Di… BiogenCell Ltd
  • Phase 2
← prev
page 7 of 50
next →
131
Pain89
Neurology1
BHV-1510
Solid Tumor
$BHVN Biohaven Ltd.
  • Phase 2
    BI-1206
    B-Cell Non-Hodgkin Lymphoma BioInvent International AB
  • Phase 2
    BI-1808
    Mycosis Fungoides BioInvent International AB
  • Phase 2
    BI-1819479
    Idiopathic Pulmonary Fibrosis Boehringer Ingelheim International GmbH
  • Phase 2
    BI-836858
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Boehringer Ingelheim International GmbH
  • Phase 2
    BIO-106
    Solid Tumor BiOneCure Therapeutics Inc
  • Phase 2
    BLB-101
    Coronavirus Disease 2019 (COVID-19) Blue Lake Biotechnology Inc
  • Phase 2
    BLB-201
    Respiratory Syncytial Virus (RSV) Infections Blue Lake Biotechnology Inc
  • Phase 2
    BLU-808
    Chronic Inducible Urticaria Blueprint Medicines Corp
  • Phase 2
    BMND-08
    Alzheimer's Disease Biomind Labs Inc
  • Phase 2
    BMS-986446
    Alzheimer's Disease Bristol-Myers Squibb Co
  • Phase 2
    BMX-001
    High-Grade Glioma Biomimetix JV LLC
  • Phase 2
    BNT-111
    Metastatic Melanoma$BNTX BioNTech SE
  • Phase 2
    BOLD-100
    Colorectal Cancer Bold Therapeutics Inc
  • Phase 2
    BOXR-1030
    Merkel Cell Carcinoma SOTIO Biotech AS
  • Phase 2
    BPZE1 vaccine
    Pertussis (Whooping Cough) ILiAD Biotechnologies LLC
  • Phase 2
    BRC-OA
    Osteoarthritis Britecyte Inc
  • Phase 2
    BRM-424
    Neurotrophic Keratitis BRIM Biotechnology Inc
  • Phase 2
    BRTX-100
    brtxDISC
    Chronic Low Back Pain (CLBP)$BRTX BioRestorative Therapies, Inc.
  • Phase 2
    BS-001
    Melanoma Wuhan Binhui Biopharmaceutical Co Ltd
  • Phase 2
    BS-01
    Retinitis Pigmentosa (Retinitis) Beacon Therapeutics Ltd
  • Phase 2
    BSI-04702
    Solid Tumor OBI Pharma Inc
  • Phase 2
    BT-7480
    Anal Cancer$BCYC BICYCLE THERAPEUTICS PLC
  • Phase 2
    BTM-3566
    Burkitt Lymphoma Bantam Pharmaceutical LLC
  • Phase 2
    BTXA-51
    Refractory Acute Myeloid Leukemia Edgewood Oncology Inc
  • Phase 2
    BW-00112
    Mixed Dyslipidemia Shanghai Argo Pharmaceutical Co Ltd
  • Phase 2
    BX-1000
    Anesthetic Effect Baudax Bio Inc